Skip to content

Tengjun Biotechnology Corp.

CIK 0001499785

← back to feed
Revenue (TTM)
$100.51M
+51,771,189.0% YoY Q2 Aug 2023
Net Income (TTM)
$7.26M
+1,617.9% YoY Q2 Aug 2023
EPS Diluted (TTM)
$0.11
+100.0% YoY Q2 Aug 2023
Gross Margin
89.6%
Q2 Aug 2023
Operating Margin
9.6%
Q2 Aug 2023
Net Margin
7.2%
Q2 Aug 2023
Free Cash Flow (TTM)
$8.69M
Q2 Aug 2023
Cash
$25.11M
Q2 Aug 2023
Total Debt
$39.18M
Q2 Aug 2023
Shares Outstanding
100.71M sh
Q2 Aug 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings